Portfolio Lab

Icu Medical Inc

  • Stock
  • Ticker ICUI
  • ISIN US44930G1076
  • Nasdaq

Health care · Medical technology · USA

$172.52 −1.84%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Icu Medical Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

ICUIGlobal equities (VT)

$10,000 grew to $11,756. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −73.8% in 11/2023, measured from the peak in 06/2018. The old peak has not been reached again yet.

1-year return
+28.4%
5-year return p.a.
−6.9%
10-year return p.a.
+1.6%
Volatility p.a.
32.8%
Largest decline
−73.8%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue630605549537541530552560
Gross profit227210208201203206235235
Operating income381311145.6143952
EBITDA9162273156645669
Net income-24-1535-3.4-16301927
Earnings per share-0.98-0.631.43-0.14-0.631.200.761.07
Balance sheet
Total assets4,2044,1854,1074,1034,0514,0143,9713,944
Liabilities2,2392,1971,9921,9761,9271,9021,8191,752
Equity1,9651,9882,1162,1272,1242,1122,1522,191
Cash309290300300308288298302
Long-term debt1,5321,4891,3381,3141,2661,2621,2121,133
Cash flow
Operating cash flow40511157613980100
Capital expenditure-24-15-20-29-25-11-19-16
Free cash flow1637-8.52836286283

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2024 at +55.6%, weakest 2023 at −36.7%. 5 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$1.07
6 Aug 2026$0.76
7 May 2026$1.20
19 Feb 2026−$0.63
6 Nov 2025−$0.14
7 Aug 2025$1.43
8 May 2025−$0.63
27 Feb 2025−$0.98
12 Nov 2024−$1.35
7 Aug 2024−$0.88
7 May 2024−$1.63
27 Feb 2024−$0.71

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€3.9bn
Market cap in trading currency
$4.31bn
Enterprise value
$5.16bn
P/E
71.9
P/S
1.98
P/B
1.97
EV/Sales
2.37
EV/EBITDA
21.1
Earnings yield
1.4%
FCF yield
4.8%

Results (last four quarters)

Revenue
$2.18bn
Gross profit
$879m
EBITDA
$245m
Net income
$60.3m
Earnings per share
$2.40
Revenue per share
$87.29
Revenue growth
+4.4%
Earnings growth
–

Profitability

Gross margin
40.3%
Operating margin
5.1%
Net margin
2.8%
Return on equity
2.8%
Return on assets
1.5%

Balance sheet and cash flow

Cash
$302m
Cash per share
$12.07
Financial debt
$1.15bn
Debt/equity %
53
Current ratio
2.37
Book value per share
$87.62
Operating cash flow
$279m
Free cash flow
$209m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
25.0m
Volume
223,429
Avg. volume 3 months
251,683
Relative volume
0.9

Price and technicals

Price
$172.52
1 day
−1.8%
52-week high
$187.26
52-week low
$115.45
Distance to 52-week high
−7.9%
Distance to 52-week low
+49.4%
Distance to 50-day line
+4.3%
Distance to 200-day line
+14.8%
RSI (14)
51
Volatility 1M
38.3%

Performance

1 week
−3.8%
1 month
+2.5%
3 months
−5.5%
6 months
+29.4%
YTD
+20.9%
1 year
+30.1%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has ICUI performed since 11/2016?

$10,000 grew to $11,756 by 20 Nov 2026, which is +1.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is ICUI?

Volatility was 32.8% per year, measured on monthly returns. The largest decline from a peak was −73.8%, with the low in 11/2023.

How does ICUI compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ICUI returned +1.6% at 32.8%. The correlation of monthly returns was 0.32; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Icu Medical Inc (ICUI): Return and risk | Portfolio Lab